Page 10 - index

Fibrillazione Atriale in Medicina Generale

care burden and treatment of atrial fbrillation in quency, patient characteristics, treatment strate-
Scotland. Heart 2007;93:606-12. gies and re source utilization of atrial fbrillation
3 Ovsyshcher E. Fibrillazione atriale: analisi epidemio- (from the Italian Survey of Atrial Fibrillation manage-
logica. G Ital Aritmol Cardiostim 2005;1;1-5. ment [ISAF] study). Am J Cardiol 2013;111:705-11.
4 www.cuore.iss.it. 17 Stewart S, Hart CL, Hole DJ, McMurray JJ. Popu-
5 Feinberg WM, Blackshear JL, Laupacis A, et al. lation prevalence, incidence, and predictors of
Prevalence, age distribution, and gender of pa- atrial fbrillation in the Renfrew/Paisley study. Heart
tients with atrial fbrillation. Analysis and implica- 2001;86:516-21.
tions. Arch Intern Med 1995;155:469-73. 18 Nieuwlaat R, Prins MH, Le Heuzey JY, et al. Prog-
6 Bialy D, Lehmann MH, Schumacher DN, et al. Hos- nosis, disease progression, and treatment of atrial
pitalization for arrhythmia in the United States: im- fbrillation patients during 1 year: follow-up of the
portance of atrial fbrillation (Abstract). J. Am Coll Euro Heart Survey on atrial fbrillation. Eur Heart J
Cardiol 1992;19:41A. 2008;29:1181-9.
7 Steward S, Mac Intyre K, Mac Leod MMC, et al. 19 Meinertz T, Kirch W, Rosin L, et al. Management of
Trends in hospital activity, morbidity and case fa- atrial fbrillation by primary care physicians in Ger-
tality related to atrial fbrillation in Scotland, 1986- many: baseline results of the ATRIUM registry. Clin
1996. Eur Hearth J 2001;22:693-701. Res Cardiol 2011;100:897-905.
8 Lloyd-Jones DM, Wang TJ, Benjamin EJ, et al. 20 Kozlowski D, Budrejko S, Lip GY, et al. Lone atrial f-
Lifetime risk for development of atrial fbrilla- brillation: what do we know? Heart 2010;96:498-503.
tion: the Framingham Heart Study. Circulation 21 Patton KK, Zacks ES, Chang JY, et al. Clinical sub-
2004;110:1042-6. types of lone atrial fbrillation. Pacing Clin Electro-
9 Levy S, Maarek M, Coumel P, et al. Character- physiol 2005;28:630-8.
ization of different subsets of atrial fbrillation 22 Psaty BM, Manolio TA, Kuller LH, et al. Incidence of
in general practice in France: the ALFA study. and risk factors for atrial fbrillation in older adults.
The College of French Cardiologists. Circulation Circulation 1997;96:2455-61.
1999;99:3028-35. 23 Stewart S, Hart CL, Hole DJ, et al. A population-
10 Sawin CT, Geller A, Kaplan MM, et al. Low serum based study of the long-term risks associated with
thyrotropin (thyroid-stimulating hormone)in older atrial fbrillation: 20-year follow-up of the Renfrew/
persons without hyperthyroidism. Arch Intern Med Paisley study. Am J Med 2002;113:359-364.
1991;151:165-8. 24 Krahn AD, Manfreda J, Tate RB, et al. The natural
11 Dries DL, Exner DV, Gersh BJ, et al. Atrial fbrilla- history of atrial fbrillation: incidence, risk factors,
tion is associated with an increased risk for mor- and prognosis in the Manitoba Follow-Up Study.
tality and heart failure progression in patients with Am J Med 1995;98:476-84.
asymptomatic and symptomatic left ventricular 25 Wolf PA, Abbott RD, Kannel WB. Atrialfbrillation: a
ventricular systolic dysfunction: a retrospective major contributor to stroke in the elderly. The Fram-
analysis of the SOLVD trials. J Am Coll Cardiol ingham Study. Arch Intern Med 1987;147:1561-4.
1998;32:695-703. 26 Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular
12 The CONSENSUS Trial Study Group. Effect of enal- trends in incidence of atrial fbrillation in Olmsted
april on mortality in severe congestive heart failure. County, Minnesota,1980 to 2000, and implications
Results of the Cooperative North Scandinavian on the projections for future prevalence. Circulation
Enalapril Survival Study (CONSENSUS). N Engl J 2006;114:119-25.
Med 1987;316:1429-35. 27 Atrial Fibrillation Investigators. Risk factors for
13 Merrit RE, Shrager B. Prophylasxis and manage- stroke and effcacy of antithrombotic therapy in
ment of atrial fbrillation after general thoracic sur- atrial fbrillation. Analysis of pooled data from fve
gery. Thorac Surg Clin 2012;22:13-23. randomized controlled trials. Arch Intern Med
14 Bilato C, Corti MC, Baggio G, et al. Prevalence, 1994;154:1449-57.
Functional Impact, and Mortality of Atrial Fibrilla- 28 Wolf PA, Abbott RD, Kannel WB. Atrial fbrillation as
tion in an Older Italian Population (from the Pro.V.A. an independent risk factor forstroke: the Framing-
Study). AM J Cardiol 2009;104:1092-7. ham Study. Stroke 1991;22:983-8.
15 Piccinocchi G, Laringe M, Guillaro B, et al. Diag- 29 Lamassa M, Di Carlo A, Pracucci G, et al. Char-
nosis and management of atrial fbrillation by pri- acteristics, outcome, and care of stroke associ-
mary care physicians in Italy: a retrospective, ob- ated with atrial fbrillation in Europe: data from a
servational analysis. Naples: Cooperativa Medicina multicenter multinational hospital-based registry
Generale Italy; in press. (the European CommunityStroke Project). Stroke
16 Zoni Berisso M, Filippi A, Landolina M, et al. Fre- 2001;32:392-8.

8